103 related articles for article (PubMed ID: 28163892)
1. Targeted pharmacotherapy after somatic cancer mutation screening.
Polasek TM; Ambler K; Scott HS; Sorich MJ; Kaub PA; Rowland A; Wiese MD; Kichenadasse G
F1000Res; 2016; 5():1551. PubMed ID: 28163892
[TBL] [Abstract][Full Text] [Related]
2. Current and evolving biomarkers for precision oncology in the management of metastatic colorectal cancer.
Henry JT; Johnson B
Chin Clin Oncol; 2019 Oct; 8(5):49. PubMed ID: 31500426
[TBL] [Abstract][Full Text] [Related]
3. Comparisons between the National Comprehensive Cancer Network (NCCN) non-small-cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009.
Xu Y; Liu H; Chen J; Zhou Q
Thorac Cancer; 2010 Jul; 1(2):83-86. PubMed ID: 27755782
[TBL] [Abstract][Full Text] [Related]
4. Treatment Patterns by EGFR Mutation Status in Non-Small Cell Lung Cancer Patients in the USA: A Retrospective Database Analysis.
Aguilar KM; Winfree KB; Muehlenbein CE; Zhu YE; Wilson T; Wetmore S; Nadler ES
Adv Ther; 2018 Nov; 35(11):1905-1919. PubMed ID: 30341504
[TBL] [Abstract][Full Text] [Related]
5. Somatic DNA mutation analysis in targeted therapy of solid tumours.
Yu B; O'Toole SA; Trent RJ
Transl Pediatr; 2015 Apr; 4(2):125-38. PubMed ID: 26835368
[TBL] [Abstract][Full Text] [Related]
6. Advanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study.
Liang R; Meiser B; Smith S; Kasparian NA; Lewis CR; Chin M; Long GV; Ward R; Menzies AM; Harris-Wai JN; Kaur R
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27730730
[TBL] [Abstract][Full Text] [Related]
7. Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung Cancer.
Shen C; Kehl KL; Zhao B; Simon GR; Zhou S; Giordano SH
Clin Lung Cancer; 2017 Jul; 18(4):e233-e241. PubMed ID: 28024927
[TBL] [Abstract][Full Text] [Related]
8. First-line systemic therapy practice patterns and concordance with NCCN guidelines for patients diagnosed with metastatic NSCLC treated at NCCN institutions.
Zornosa C; Vandergrift JL; Kalemkerian GP; Ettinger DS; Rabin MS; Reid M; Otterson GA; Koczywas M; D'Amico TA; Niland JC; Mamet R; Pisters KM
J Natl Compr Canc Netw; 2012 Jul; 10(7):847-56. PubMed ID: 22773800
[TBL] [Abstract][Full Text] [Related]
9. Personalised cancer medicine.
Jackson SE; Chester JD
Int J Cancer; 2015 Jul; 137(2):262-6. PubMed ID: 24789362
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non-Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older.
Battisti NML; Sehovic M; Extermann M
Clin Lung Cancer; 2017 Sep; 18(5):460-471. PubMed ID: 28416124
[TBL] [Abstract][Full Text] [Related]
11. Targeted Therapy for Patients With Metastatic Non-Small Cell Lung Cancer.
Reckamp KL
J Natl Compr Canc Netw; 2018 May; 16(5S):601-604. PubMed ID: 29784736
[TBL] [Abstract][Full Text] [Related]
12. Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal.
Zagouri F; Liakou P; Bartsch R; Peccatori FA; Tsigginou A; Dimitrakakis C; Zografos GC; Dimopoulos MA; Azim HA
Breast; 2015 Aug; 24(4):513-23. PubMed ID: 25818651
[TBL] [Abstract][Full Text] [Related]
13. Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.
Nakayama I; Shinozaki E; Matsushima T; Wakatsuki T; Ogura M; Ichimura T; Ozaka M; Takahari D; Suenaga M; Chin K; Mizunuma N; Yamaguchi K
BMC Cancer; 2017 Jan; 17(1):38. PubMed ID: 28068936
[TBL] [Abstract][Full Text] [Related]
14. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
15. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
16. Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small-Cell Lung Cancer: A Network Meta-Analysis.
Li J; Sasane M; Zhao J; Horton VG; Zhang P; Ricculli ML; Zhou ZY; Signorovitch J
Adv Ther; 2018 Jul; 35(7):1035-1048. PubMed ID: 29949047
[TBL] [Abstract][Full Text] [Related]
17. Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches.
Shea M; Costa DB; Rangachari D
Ther Adv Respir Dis; 2016 Apr; 10(2):113-29. PubMed ID: 26620497
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial.
Tournigand C; Chibaudel B; Samson B; Scheithauer W; Vernerey D; Mésange P; Lledo G; Viret F; Ramée JF; Tubiana-Mathieu N; Dauba J; Dupuis O; Rinaldi Y; Mabro M; Aucoin N; Latreille J; Bonnetain F; Louvet C; Larsen AK; André T; de Gramont A
Lancet Oncol; 2015 Nov; 16(15):1493-1505. PubMed ID: 26474518
[TBL] [Abstract][Full Text] [Related]
19. KIT as an Oncogenic Driver in Melanoma: An Update on Clinical Development.
Meng D; Carvajal RD
Am J Clin Dermatol; 2019 Jun; 20(3):315-323. PubMed ID: 30707374
[TBL] [Abstract][Full Text] [Related]
20. Metastatic colorectal cancer treatment patterns according to kirsten rat sarcoma viral oncogene homolog genotype in U.S. Community-based oncology practices.
Landsman-Blumberg PB; Carter GC; Johnson BH; Sedgley R; Nicol SJ; Li L; Shankaran V
Clin Colorectal Cancer; 2014 Sep; 13(3):178-84. PubMed ID: 25065655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
